Literature DB >> 9928833

Nuclear inclusions in spinocerebellar ataxia type 1.

C Duyckaerts1, A Dürr, G Cancel, A Brice.   

Abstract

Spinocerebellar ataxia type 1 is due to a CAG repeat expansion in the gene encoding ataxin-1. In a case with an expansion of 56 repeats, intranuclear inclusions were found only in neurons, both in severely affected regions (such as the pons) and in areas where the lesions were inconspicuous (such as the cortex or the striatum). The inclusions were labelled by a monoclonal antibody directed against long polyglutamine stretches (1C2); they were also detected by the anti-ubiquitin antibody. They were faintly eosinophilic, Congo red negative and were not stained by thioflavin S or by ethidium bromide.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9928833     DOI: 10.1007/s004010050975

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  11 in total

1.  Unexpected clinicopathological phenotype linked to small elongation of CAG repeat in SCA1 gene.

Authors:  T Uchihara; Y Takeda; T Kobayashi; T Kasuga; K Ishikawa; K Kirei; H Mizusawa; T Endo; K Hirokawa; T Kuroiwa
Journal:  J Neurol       Date:  2005-11-29       Impact factor: 4.849

2.  Structural signature in SCA1: clinical correlates, determinants and natural history.

Authors:  Carlos Roberto Martins Junior; Alberto Rolim Muro Martinez; Ingrid Faber Vasconcelos; Thiago Junqueira Ribeiro de Rezende; Raphael Fernandes Casseb; Jose Luiz Pedroso; Orlando Graziani Povoas Barsottini; Íscia Lopes-Cendes; Marcondes Cavalcante França
Journal:  J Neurol       Date:  2018-10-15       Impact factor: 4.849

Review 3.  The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. A review.

Authors:  R Walsh; E Storey; D Stefani; L Kelly; V Turnbull
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

4.  Distribution and pattern of pathology in subjects with familial or sporadic late-onset cerebellar ataxia as assessed by p62/sequestosome immunohistochemistry.

Authors:  Maria Pikkarainen; Päivi Hartikainen; Hilkka Soininen; Irina Alafuzoff
Journal:  Cerebellum       Date:  2011-12       Impact factor: 3.847

5.  Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy.

Authors:  Megan S Keiser; Jeffrey H Kordower; Pedro Gonzalez-Alegre; Beverly L Davidson
Journal:  Brain       Date:  2015-10-21       Impact factor: 13.501

6.  Both ubiquitin ligases FBXW8 and PARK2 are sequestrated into insolubility by ATXN2 PolyQ expansions, but only FBXW8 expression is dysregulated.

Authors:  Melanie Vanessa Halbach; Tanja Stehning; Ewa Damrath; Marina Jendrach; Nesli Ece Şen; A Nazlı Başak; Georg Auburger
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

7.  Cross-species genetic screens identify transglutaminase 5 as a regulator of polyglutamine-expanded ataxin-1.

Authors:  Won-Seok Lee; Ismael Al-Ramahi; Hyun-Hwan Jeong; Youjin Jang; Tao Lin; Carolyn J Adamski; Laura A Lavery; Smruti Rath; Ronald Richman; Vitaliy V Bondar; Elizabeth Alcala; Jean-Pierre Revelli; Harry T Orr; Zhandong Liu; Juan Botas; Huda Y Zoghbi
Journal:  J Clin Invest       Date:  2022-05-02       Impact factor: 19.456

8.  Monomeric, oligomeric and polymeric proteins in huntington disease and other diseases of polyglutamine expansion.

Authors:  Guylaine Hoffner; Philippe Djian
Journal:  Brain Sci       Date:  2014-03-03

Review 9.  Pathology and function of nuclear amyloid. Protein homeostasis matters.

Authors:  Anna von Mikecz
Journal:  Nucleus       Date:  2014 Jul-Aug       Impact factor: 4.197

Review 10.  Disrupted Calcium Signaling in Animal Models of Human Spinocerebellar Ataxia (SCA).

Authors:  Francesca Prestori; Francesco Moccia; Egidio D'Angelo
Journal:  Int J Mol Sci       Date:  2019-12-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.